Kinetic studies have shown that IRF1 induction by IFNβ is required for the initial amplification of the inflammatory response to viral infection, but that sustained antiviral protection relies on type III IFNs (Forero et al, 2019). The gene discussed is IFNB1; the disease is viral infectious disease.